Equitable Holdings
EQH
$41.60
+0.07%
Equitable Holdings, Inc. is a diversified financial services company operating primarily in the insurance and asset management sectors, providing retirement solutions, asset management, and wealth management services to individual and institutional clients. The company is a significant player in the U.S. retirement and annuity market, with its Retirement segment being the primary revenue driver, and its identity is further solidified by its ownership of the global asset manager, AB (AllianceBernstein). The current investor narrative is heavily influenced by the company's volatile earnings performance, as evidenced by a significant net loss in Q3 2025 followed by a return to profitability in Q4, coupled with management's confidence signaled through a recently announced substantial share repurchase program.…
EQH
Equitable Holdings
$41.60
Related headlines
Investment Opinion: Should I buy EQH Today?
Rating: Hold. The core thesis is that EQH presents a high-risk, high-potential-reward situation where severe fundamental flaws are counterbalanced by an extreme valuation discount and strong institutional support, making it unsuitable for most investors but potentially interesting for deep-value, risk-tolerant specialists.
Supporting evidence includes a forward P/E of 4.72 based on a $12.50 EPS estimate, implying massive upside if achieved, and a Price-to-Sales ratio of 1.22 near its historical low. The company generated $737M in TTM free cash flow and holds $12.96B in cash, providing a liquidity moat. Furthermore, five major banks maintain Buy/Overweight ratings, and the recent announcement of a substantial buyback program signals capital return commitment.
The thesis would upgrade to a Buy if the company reports two consecutive quarters of stable, profitable earnings (validating the forward P/E) and provides clarity on resolving the negative equity situation. It would downgrade to a Sell if Q1 2026 results show a return to significant net losses or if the stock breaks decisively below the $35.20 support on high volume. Relative to its own volatile history and the risks involved, the stock is fairly valued—the low P/E accurately reflects the high probability of continued earnings disappointment.
Sign up to view all
EQH 12-Month Price Forecast
The investment case for EQH is bifurcated. The valuation is undeniably cheap, and the company has the liquidity to survive turbulence and reward shareholders via buybacks. However, the fundamental instability in earnings and the negative equity are profound, non-quantitative risks that the low P/E may not adequately discount. The stance is neutral, as the high probability base case suggests range-bound trading. Confidence is medium due to the sparse analyst coverage. The stance would upgrade to bullish on evidence of sustained quarterly profitability; it would downgrade to bearish on another large quarterly loss or a break below $35 support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Equitable Holdings's 12-month outlook, with a consensus price target around $54.08 and implied upside of +30.0% versus the current price.
Average Target
$54.08
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$33 - $54
Analyst target range
Analyst coverage is very limited, with only two firms providing estimates, which implies this is not a widely followed large-cap name and can lead to higher volatility and less efficient price discovery. The consensus among the few analysts is bullish, with an average EPS estimate of $12.50 for the coming period, ranging from a low of $10.97 to a high of $13.38, indicating expectations for a strong recovery in profitability from the depressed trailing results. Institutional ratings from major banks, however, show consistent support, with recent actions from Morgan Stanley, Wells Fargo, UBS, JP Morgan, and Barclays all maintaining 'Overweight' or 'Buy' ratings, suggesting professional money managers see value at current levels despite the fundamental challenges.
Bulls vs Bears: EQH Investment Factors
The evidence presents a stark dichotomy: compelling valuation and liquidity arguments versus severe fundamental instability. The bear case currently holds stronger evidence due to the concrete, recurring issues of catastrophic earnings volatility and a leveraged balance sheet with negative equity—these are existential financial statement concerns. The single most important tension in the investment debate is whether the company's deep valuation discount (forward P/E of 4.72) and strong cash position ($12.96B) adequately compensate for the extreme risk of its earnings unpredictability and negative book value. The resolution hinges on whether management can stabilize investment-related results to deliver on the $12.50 analyst EPS estimate, thereby validating the low multiple.
Bullish
- Extreme Valuation Discount: The stock trades at a forward P/E of only 4.72 based on analyst EPS estimates of $12.50, representing a deep discount to the broader market and financial sector averages. This low multiple suggests the market has priced in significant pessimism, leaving room for substantial multiple expansion if earnings stabilize.
- Major banks including Morgan Stanley, Wells Fargo, UBS, JP Morgan, and Barclays all maintain 'Overweight' or 'Buy' ratings, indicating professional conviction in a recovery. This institutional support, coupled with a recently announced substantial share repurchase program, signals management confidence and provides a potential technical floor.
- Robust Liquidity & Cash Flow: The company holds a substantial cash position of $12.96 billion and generated $737 million in TTM free cash flow. This strong liquidity provides a significant buffer against operational volatility and funds shareholder returns, mitigating balance sheet concerns despite the negative equity.
- Oversold Technical Condition: The stock trades at $41.73, just 18% above its 52-week low of $35.20 and has underperformed the S&P 500 by -45.87% over the past year. This deep value territory, combined with a recent 10.28% 1-month bounce, suggests the severe selling pressure may be exhausted, setting up for a potential mean reversion.
Bearish
- Catastrophic Earnings Volatility: Profitability has swung wildly, from a net income of $215 million in Q4 2025 to a loss of -$1.31 billion in Q3, with a trailing twelve-month EPS of -$0.097. This extreme volatility, driven by investment losses, makes forecasting nearly impossible and destroys investor confidence.
- Severely Leveraged Balance Sheet: The company reports a debt-to-equity ratio of -88.68 due to negative shareholder equity, a critical red flag that indicates liabilities exceed assets. This precarious capital structure heightens financial risk and limits strategic flexibility, especially in a rising rate environment.
- Erratic Revenue Trajectory: Revenue has been highly inconsistent, declining -9.5% YoY in Q4 2025 to $3.28B after plummeting to $1.45B in Q3 from $3.90B in Q1. This lack of top-line stability suggests dependence on unpredictable investment-related gains rather than stable fee income.
- Persistent Underperformance & Weak Sentiment: The stock has declined -10.97% over the past year while the S&P 500 gained 34.9%, and it remains in a pronounced downtrend. This severe relative weakness of -45.87 reflects deep-seated negative sentiment and company-specific headwinds that a low P/E alone may not overcome.
EQH Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -10.97% and a 6-month decline of -11.98%, significantly underperforming the S&P 500's 34.9% gain over the same period. Currently trading at $41.73, the price sits just 18% above its 52-week low of $35.195 and 26% below its 52-week high of $56.61, positioning it in the lower quartile of its annual range, which suggests deep value territory but also reflects persistent selling pressure and negative sentiment. Recent momentum shows a short-term bounce, with a 1-month gain of 10.28% against a 3-month loss of -10.70%, indicating a potential oversold relief rally or mean reversion attempt, though this nascent recovery remains fragile within the broader bearish context. Key technical support is clearly defined at the $35.20 low, while initial resistance lies near the $56.61 high; a sustained break below support could trigger a new leg down, whereas reclaiming the $45-$48 zone would be necessary to suggest a trend reversal. With a beta of 1.11, the stock exhibits marginally higher volatility than the broader market, which is typical for financials, but its severe underperformance (relative strength of -45.87 over one year) highlights significant company-specific or sector-specific headwinds.
Beta
1.11
1.11x market volatility
Max Drawdown
-37.0%
Largest decline past year
52-Week Range
$35-$57
Price range past year
Annual Return
-14.9%
Cumulative gain past year
| Period | EQH Return | S&P 500 |
|---|---|---|
| 1m | +10.7% | +8.5% |
| 3m | -8.9% | +2.8% |
| 6m | -14.9% | +4.6% |
| 1y | -14.9% | +32.3% |
| ytd | -13.3% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EQH Fundamental Analysis
Revenue performance has been highly inconsistent and recently negative, with Q4 2025 revenue of $3.28 billion representing a -9.5% year-over-year decline, following a disastrous Q3 where revenue plummeted to $1.45 billion; this erratic trajectory, from $3.90 billion in Q1 to $1.45 billion in Q3, points to fundamental volatility likely tied to investment-related gains/losses rather than stable fee income. Profitability is equally volatile, swinging from a net income of $215 million in Q4 2025 (net margin of 6.56%) to a massive loss of -$1.31 billion in Q3 (net margin of -90.28%), while gross margin remains high at 88.07% in Q4, indicating the core insurance underwriting spread business is sound, but bottom-line results are being severely impacted by mark-to-market investment losses and potentially one-time charges. The balance sheet shows extreme leverage with a debt-to-equity ratio of -88.68, an artifact of negative shareholder equity, which is a critical red flag requiring scrutiny of the capital structure; however, the company generated $737 million in trailing twelve-month free cash flow and holds a substantial cash position of $12.96 billion, providing significant liquidity to navigate challenges and fund shareholder returns like the recently announced buyback.
Quarterly Revenue
$3.3B
2025-12
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.88%
Latest Quarter
Free Cash Flow
$737000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EQH Overvalued?
Given the trailing twelve-month net income is negative at -$0.097 per share, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 1.22, while the forward-looking valuation, implied by the market cap and analyst revenue estimates, suggests a similar sales multiple, indicating the market is not pricing in significant top-line growth. Compared to its own historical range, the current PS of 1.22 is near the lower end, as historical data shows ratios have fluctuated between approximately 2.11 and 12.28 over recent years; this depressed multiple reflects the market's punitive assessment of the company's earnings volatility and leveraged balance sheet. The stock also trades at a forward P/E of 4.72 based on analyst EPS estimates of $12.50, which appears deeply discounted, but this low multiple must be weighed against the high risk and uncertainty stemming from the company's erratic profit history and negative book value.
PE
-10.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -25x~64x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-8.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on earnings volatility and balance sheet fragility. The swing from a $1.31 billion Q3 loss to a $215 million Q4 profit exemplifies an unpredictable earnings stream tied to mark-to-market investments, making the forward P/E of 4.72 a highly speculative metric. The debt-to-equity ratio of -88.68, stemming from negative shareholder equity, indicates a capital structure where liabilities exceed assets, raising solvency concerns despite the $12.96 billion cash hoard. Revenue concentration in market-sensitive retirement products and a -9.5% YoY revenue decline in Q4 further expose the business to financial market downturns.
Market & Competitive Risks include valuation trap potential and sector headwinds. While the PS ratio of 1.22 is near its historical low, the stock could remain cheap if earnings volatility persists, compressing multiples further. With a beta of 1.11, EQH is slightly more volatile than the market, and its -45.87 relative strength indicates it is suffering from severe company-specific de-rating rather than broad sector weakness. Competitive pressures in the crowded annuity and asset management space could pressure fee income, while regulatory changes affecting retirement products pose additional external threats.
Worst-Case Scenario involves a renewed downturn in financial markets triggering another quarter of massive investment losses, similar to Q3 2025. This could lead to a credit rating downgrade, forcing asset sales and crippling the core spread business. Investor confidence would evaporate, pushing the stock to retest and break its 52-week low of $35.20. A realistic downside from the current $41.73 is approximately -16% to that technical support level, but a break below could trigger a steeper decline towards the $30 range, representing a potential loss of -25% to -30%.
FAQ
The key risks, in order of severity, are: 1) Earnings Volatility Risk: The company's profits are highly unpredictable due to mark-to-market investment losses, as seen in the -$1.31B Q3 2025 net income. 2) Balance Sheet Risk: Negative shareholder equity results in a debt-to-equity ratio of -88.68, indicating a fragile capital structure. 3) Sentiment & Technical Risk: The stock has underperformed the S&P 500 by -45.87% over one year and sits just 18% above its 52-week low, reflecting persistent negative momentum. 4) Coverage Risk: With only two analyst estimates, the stock suffers from low visibility and potentially inefficient price discovery.
The 12-month forecast is highly scenario-dependent. The base case (50% probability) sees the stock trading between $42 and $48 as volatility persists. The bull case (25% probability), should earnings stabilize, targets $56-$60 based on a re-rating from the current forward P/E. The bear case (25% probability), triggered by another large quarterly loss, could see the stock fall to $30-$35, retesting or breaking its 52-week low. The base case is most likely, predicated on the assumption that EQH avoids another catastrophe but fails to deliver consistent profits at the $12.50 EPS estimate level.
EQH appears statistically undervalued based on traditional metrics. Its forward P/E of 4.72 and Price-to-Sales ratio of 1.22 are near historical lows. However, this 'cheapness' is likely a value trap that accurately reflects the company's profound fundamental risks, including negative book value and erratic profitability. Compared to more stable financial peers, EQH trades at a deep discount, which the market demands as compensation for its higher risk. The valuation implies the market expects continued earnings disappointment and assigns a high probability to the bear case.
EQH is a high-risk, high-potential-reward stock that is not a 'good buy' for most investors. For a deep-value, risk-tolerant specialist, it may be compelling due to its extreme valuation discount (forward P/E of 4.72) and strong institutional support. However, the severe earnings volatility, evidenced by a swing from a -$1.31B loss to a $215M profit in consecutive quarters, and the negative shareholder equity make it highly speculative. It could be a good buy only for those who believe the company will consistently deliver on the $12.50 analyst EPS estimate and who have a high risk tolerance.
EQH is unsuitable for short-term trading due to its high beta (1.11) and earnings-driven volatility, which can cause sharp, unpredictable moves around quarterly reports. It is also a poor fit for traditional long-term 'buy-and-hold' portfolios because of its fundamental instability. It is best suited for a medium-term, event-driven horizon (12-24 months) for investors betting on a specific turnaround catalyst, such as the stabilization of quarterly earnings. A minimum holding period through at least two more earnings reports is necessary to assess whether the recovery thesis is intact.